Results 241 to 250 of about 145,467 (273)

Major Bleeding Risk During Anticoagulation with Warfarin, Dabigatran, Apixaban, or Rivaroxaban in Patients with Nonvalvular Atrial Fibrillation.

open access: yesJournal of Managed Care & Specialty Pharmacy, 2017
G. Adeboyeje   +7 more
semanticscholar   +1 more source

Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine

open access: gold, 2015
Mirjana Stupnišek   +11 more
openalex   +2 more sources

Acute subdural haemorrhage in a warfarin user following leech bite: Clinical note and review

open access: diamond
Aviraj S. Deshmukh   +4 more
openalex   +1 more source

Association of Warfarin Therapy with APOE and VKORC1 Genes Polymorphism in Iranian Population.

open access: green, 2017
Sajad Rafiee   +8 more
openalex   +1 more source

Effects of Warfarin on the Risks of Mortality, Acute Heart Failure, and Infection Resolution in Patients with Infective Endocarditis: A Target Trial Emulation

open access: green
Teddy Lee   +11 more
openalex   +1 more source

Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation

open access: yesNew England Journal of Medicine, 2011
Manesh R Patel   +2 more
exaly   +3 more sources

Direct Oral Anticoagulants Versus Warfarin in Patients With Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials With Interaction Testing by Age and Sex

open access: yesCirculation, 2022
Supplemental Digital Content is available in the text. Background: Direct oral anticoagulants (DOACs) are preferred over warfarin for stroke prevention in atrial fibrillation.
Anthony P Carnicelli   +2 more
exaly   +2 more sources

Home - About - Disclaimer - Privacy